ArticleEuropean journal of pediatrics2021

Correction to: Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study.

Ruth Garcia-Romero et al.PubMed ↗Publisher ↗

No numbers read from the abstract.